A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome® gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise. Issue 1 (2nd January 2016)
- Record Type:
- Journal Article
- Title:
- A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome® gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise. Issue 1 (2nd January 2016)
- Main Title:
- A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome® gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise
- Authors:
- Seidel, Egbert J.
Rother, Matthias
Regenspurger, Katja
Rother, Ilka - Abstract:
- Abstract: We compared the effectiveness of topical ketoprofen in Transfersome ® gel (IDEA-033) with oral ketoprofen and drug-free Sequessome™ vesicles (FLEXISEQ ® Sport; TDT 064) in reducing calf muscle soreness. One hundred and sixty eight healthy individuals with a pain score ≥3 (10-point scale) 12–16 h post-exercise (walking down stairs with an altitude of 300–400 m) were randomised to receive IDEA-033 plus oral placebo (two dose groups), oral ketoprofen plus TDT 064, or TDT 064 plus oral placebo. The primary endpoint was muscle soreness reduction from pre-dosing to Day 7. Higher pain scores were recorded with oral ketoprofen plus TDT 064 (mean ± s 462.4 ± 160.4) versus IDEA-033 plus oral placebo (434.7 ± 190.8; P = 0.2931) or TDT 064 plus oral placebo (376.2 ± 159.1; P = 0.0240) in the 7 days post-exercise. Recovery from muscle soreness was longer with oral ketoprofen plus TDT 064 (mean 91.0 ± 19.5 h) versus IDEA-033 plus placebo (mean 81.4 ± 22.9 h; P = 0.5964) or TDT 064 plus placebo (mean 78.9 ± 22.8 h; P = 0.0262). In conclusion, ultradeformable phospholipid vesicles ± ketoprofen did not retard recovery from muscle soreness. TDT 064 improves osteoarthritis-related pain and could be of interest as a treatment for joint pain during and post-exercise.
- Is Part Of:
- Journal of sports sciences. Volume 34:Issue 1(2016)
- Journal:
- Journal of sports sciences
- Issue:
- Volume 34:Issue 1(2016)
- Issue Display:
- Volume 34, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 34
- Issue:
- 1
- Issue Sort Value:
- 2016-0034-0001-0000
- Page Start:
- 88
- Page End:
- 95
- Publication Date:
- 2016-01-02
- Subjects:
- exercise -- IDEA-033 -- oral NSAID -- muscle soreness -- TDT 064 -- joint pain
Sports -- Periodicals
Sports -- Physiological aspects -- Periodicals
Sports -- Psychological aspects -- Periodicals
612.044 - Journal URLs:
- http://www.tandfonline.com/toc/rjsp20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/02640414.2015.1035667 ↗
- Languages:
- English
- ISSNs:
- 0264-0414
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5066.350000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12823.xml